Hims & Hers Health Stock Falls as FDA Drops Eli Lilly
WEB17 hours ago · Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply. The FDA ...
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly…
WEB13 hours ago · Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...
Hims & Hers Health Shares Fall After FDA Removes Eli Lilly …
WEB1 day ago · Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes drugs are no longer in shortage. Shares were down 7% in premarket trading to $17.64.
Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped …
WEB20 hours ago · HIMS. Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signaling the pharmaceutical giant's ...
Eli Lilly GLP-1 shortage officially ends, hurting Hims & Hers
WEB1 day ago · Eli Lilly GLP-1 shortage officially ends, hurting Hims & Hers Oct. 03, 2024 5:54 AM ET Eli Lilly and Company (LLY) Stock , HIMS Stock NVO By: Preeti Singh , SA News Editor 2 Comments Play ( 2min )
Eli Lilly weight-loss drug shortage ends, shaking up telehealth
WEB19 hours ago · Eli Lilly weight-loss drug shortage ends, shaking up telehealth ... Shares of Hims & Hers Health Inc., a telehealth company that sells copycat weight-loss drugs, fell as much as 9.8% before ...
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
WEB16 hours ago · Hims & Hers Health ’s HIMS -10.53% stock more than doubled after it started offering weight-loss drugs this year. The pivot has made the stock sensitive to any sign of trouble in the GLP-1 space ...
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
WEB1 day ago · The FDA now agrees. (AP Photo/Darron Cummings) By Hannah Ziegler. and. Daniel Gilbert. October 2, 2024 at 8:39 p.m. EDT. The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes ...
FDA removes Lilly's Mounjaro and Zepbound from its shortage list
WEB1 day ago · Eli Lilly’s tirzepatide has been erased from the FDA’s shortage list, ... By mid-morning on Thursday, the share price of Hims & Hers Health, a telehealth seller of prescription drugs, ...
HIms and Hers shares drop after FDA says Lilly's weight-loss drug …
WEB1 day ago · Analysts at BMO Capital Markets said the news was a "clear positive" for Eli Lilly's manufacturing capabilities, and "puts pressure on compounded GLP-1s," referring to the class of drugs designed ...
- Some results have been removed